FDA Approves CaloMist Nasal Spray for Vitamin B12 Deficiency
The United States Food and Drug Administration (FDA) has approved CaloMist Nasal Spray (cyanocobalamin, USP) for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with vitamin B12 deficiency who have no nervous system involvement.Posted: July 2007
CaloMist (cyanocobalamin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
